28 April 2020 - EMA has endorsed a joint COVID-19 statement published today by the International Coalition of Medicines Regulatory ...
17 April 2020 - The National Institutes of Health (NIH) and the Foundation for the NIH are bringing together more than ...
14 April 2020 - Candidate vaccine expected to enter clinical trials in the second half of 2020 and, if successful, to ...
6 April 2020 - Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the ...
3 April 2020 - On 2 April, regulators from around the world joined the second workshop on COVID-19 organised by ...
1 April 2020 - Never before, scientists say, have so many of the world’s researchers focused so urgently on a single ...
26 March 2020 - “We are trying to fly the plane while we are building it.” ...
26 March 2020 - As our society becomes more global, it has become increasingly clear that the U.S. FDA needs to ...
26 March 2020 - Collaboration to address product development and scale up challenges posed by current pandemic. ...
23 March 2020 - Vaccines offer a way to build immunity to a disease-causing microorganism before one has ever been exposed ...
19 March 2020 - EMA’s Human Medicines Committee has published a statement urging the EU research community to prioritise large randomised ...
5 March 2020 - The Therapeutic Goods Administration (TGA) has approved a new medicine for the treatment of influenza (flu) as ...
2 December 2019 - The EMA and the US FDA have committed to engaging patients in their regulatory processes to promote ...
26 November 2019 - Deferred prosecution agreements among resolutions discussed. ...
25 November 2019 - The Therapeutic Goods Administration has approved the use of acalabrutinib (Calquence) for the treatment of patients ...